mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

Clinical trial NCT06778317 · RECRUITING

Trial details

NCT number: NCT06778317
Sponsor: Central Hospital, Nancy, France
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma (HCC)Cirrhosis Risk Prediction for Liver Cancer Epigenomics

Start date: 2025-06-03
Primary completion: 2033-06-03
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.